For every $1 we spend in seed funding through the Future Leaders in Canadian Brain Research program, Future Leaders will attract an additional $7.75 to build on their findings.
For every $1 we spend in seed funding through the Future Leaders in Canadian Brain Research program, Future Leaders will attract an additional $7.75 to build on their findings. Since 2019, the Future Leaders program has supported 131 promising early career researchers with $100,000 each to pursue bold ideas, advance their research programs, and launch their careers. This seed funding has allowed Future Leaders to:
Something remarkable happens when a 22-year-old and a 75-year-old stand side by side rolling dough or tossing a Thai-inspired salad. Conversation flows. Memories surface. Skills are exchanged. That, in essence, is the premise and growing proof behind Cooking Together, an innovative multi-week intergenerational cooking and nutrition program.
In 2016, Yasser Iturria-Medina, Ph.D., and his post-doctoral supervisor at the time, Alan Evans, Ph.D., published findings that quietly helped shift how scientists think about Alzheimer’s disease. Today, that work has informed several therapeutic patents and opened the door to a distinct class of drug targets currently being tested on patients around the world.
Cause of sex-dependent vulnerability in Alzheimer’s
A research team led by Dr. Jonathan Epp, PhD, and Dr. Derya Sargin, PhD, at the University of Calgary, funded by Brain Canada and Women’s Brain Health Initiative (WBHI), has identified a potentially promising target for new Alzheimer’s disease treatments. The results were recently published in Science Advances.
In 2021 we reported on the progress of Dr. Mari DeMarco’s IMPACT-AD project funded in part by Brain Canada, which was evaluating the implementation of a comprehensive biomarker testing strategy for Alzheimer’s disease.
